FTC sues key pharmacy gain professionals around insulin rates The agency brought motion from Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the list cost of existence-conserving insulin medication. Earlier this summer time, the agency held prolonged negotiations with Steward in excess of https://devinwtpid.idblogmaker.com/30040676/5-easy-facts-about-healthcare-news-described